It remains to be determined how GLP-1 confers its kidney benefits, as the only GLP-1 receptor that has been identified has limited expression in the kidney (8)
Discontinuing treatment should be discussed with a medical practitioner, as lifestyle changes may be needed to maintain results
Factors such as dosing frequency, route of administration (injectable or oral), and potential side effects may influence the selection process
These findings may result from a direct interaction between Y1-R and GLP-1R and/or the impact of Y1-R signaling on GLP-1R-mediated induction of cAMP
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced s Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH